Centene (CNC) Could Be 5% Undervalued On Raised 2026 Guidance

Why Centene’s updated outlook is moving the stock

Centene (CNC) is back in focus after raising its 2026 revenue and earnings guidance, following third quarter results that combined higher sales with a small loss and an earlier than expected Medicare Advantage break-even.

The guidance upgrade and Medicare Advantage progress come against a backdrop of strong momentum for Centene. The stock has slipped 5.97% on a 1-day share price return, yet it still shows a 6.70% 30-day share price return and a 66.92% year to date share price return, while the 1-year total shareholder return of 85.68% contrasts with slightly negative total shareholder returns over 3 and 5 years. This pattern suggests investors are reassessing both growth potential and risk after a tougher longer stretch.

Scan how Centene’s guidance upgrade compares with peers by reviewing companies on the move in our 38 high quality undervalued stocks.

After a near 67% year to date climb and fresh guidance that lifted 2026 revenue and earnings floors, the real puzzle on Centene now is simple: Is most of the payoff already in the share price, or is there meaningful upside left as valuation comes under the microscope next?

Most Popular Narrative: 5% Undervalued

Centene’s most followed narrative pegs fair value at $73.50, a touch above the latest $69.74 close. This puts the company’s upgraded 2026 outlook under a brighter spotlight for anyone reassessing the recent rally.

Centene's effort to restore Medicaid margins, supported by a 2026 composite rate yield outlook of roughly 5% and a targeted full year Medicaid HBR of about 93.5%, continues to point to earnings power that some investors may not yet fully reflect in valuation, with potential impact on segment net margins.

See why 62 investors see Centene as 5% undervalued.

Result: Fair Value of $73.50 (UNDERVALUED)

Still, the Centene story can change quickly if health policy support weakens or if Medicaid margin recovery and membership trends fall short of current expectations.

Find out about the key risks to this Centene narrative.

Next Steps

If the mixed sentiment on Centene leaves you on the fence, move quickly from headline impressions to the underlying data and form your own stance. To see both the upside case and the pressure points in one place, review the 4 key rewards and 2 important warning signs.

Looking for more Centene-adjacent investment ideas?

Use Centene as your reference point, then broaden your watchlist with fresh ideas that match your own preferred mix of quality, risk and potential payoff.

Miss these and you risk leaving other compelling setups on the table just as the next phase of the market cycle starts to sort the resilient from the fragile.

• Target resilience by focusing on balance sheet strength through a curated list of solid balance sheet and fundamentals (25 results) that filters for sturdier fundamentals and cleaner financial structures.
• Hunt for mispriced opportunities by scanning a focused 38 high quality undervalued stocks built to surface businesses where fundamentals and price appear out of sync.
• Prioritize staying power over drama by reviewing a 31 resilient stocks with low risk scores that spotlights companies with more measured risk profiles.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com